In Vitro Activity of Telavancin against Gram-Positive Clinical Isolates Recently Obtained in Europe

Antimicrobial Agents and Chemotherapy
2007.0

Abstract

The in vitro activity of telavancin was tested against 620 gram-positive isolates. For staphylococci, MICs at which 50 and 90% of isolates were inhibited (MIC(50) and MIC(90)) were both 0.25 microg/ml, irrespective of methicillin resistance. MIC(50) and MIC(90) were 0.25 and 0.5 microg/ml for vancomycin-susceptible enterococci and 1 and 2 microg/ml for vancomycin-resistant enterococci, respectively. Streptococcus pneumoniae, group A and B beta-hemolytic streptococci, and viridans streptococci were inhibited by < or =0.12 microg/ml.

Knowledge Graph

Similar Paper

In Vitro Activity of Telavancin against Gram-Positive Clinical Isolates Recently Obtained in Europe
Antimicrobial Agents and Chemotherapy 2007.0
In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria
Antimicrobial Agents and Chemotherapy 2008.0
Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Activity of Telavancin against a Contemporary Worldwide Collection of Staphylococcus aureus Isolates
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Activities of Telavancin and Six Comparator Agents against Anaerobic Bacterial Isolates
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activities of Telavancin and Vancomycin against Biofilm-Producing Staphylococcus aureus , S . epidermidis , and Enterococcus faecalis Strains
Antimicrobial Agents and Chemotherapy 2009.0
Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates
Antimicrobial Agents and Chemotherapy 2009.0
Activity of Telavancin against Staphylococcus aureus Strains with Various Vancomycin Susceptibilities in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations
Antimicrobial Agents and Chemotherapy 2009.0
Activities of Dalbavancin against a Worldwide Collection of 81,673 Gram-Positive Bacterial Isolates
Antimicrobial Agents and Chemotherapy 2009.0
Specificity of Induction of the vanA and vanB Operons in Vancomycin-Resistant Enterococci by Telavancin
Antimicrobial Agents and Chemotherapy 2010.0